TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Where's the Real Leadership?: Cramer's 'Mad Money' Recap (Monday 4/30/18)
JIM CRAMER

The Power of Personalization: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 24, 2018 11:04 PM EDT
PRESS RELEASES

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • By Business Wire
  • Jan 7, 2021 4:05 PM EST
PRESS RELEASES

Verastem Oncology Appoints Frank Neumann, M.D., Ph.D., As Chief Medical Officer

  • By Business Wire
  • Jan 6, 2021 9:13 AM EST
PRESS RELEASES

Verastem Oncology To Present At The H.C. Wainwright BioConnect 2021 Conference

  • By Business Wire
  • Jan 5, 2021 7:00 AM EST
PRESS RELEASES

Verastem Oncology Announces New Data Published In The Lancet Oncology Supports Potential Of VS-6766 As Treatment For RAS Mutant Tumors

  • By Business Wire
  • Oct 28, 2020 8:01 PM EDT
PRESS RELEASES

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • By Business Wire
  • Oct 6, 2020 7:00 AM EDT
PRESS RELEASES

Verastem Oncology Announces Closing Of COPIKTRA® (duvelisib) Sale To Secura Bio

  • By Business Wire
  • Sep 30, 2020 8:54 AM EDT
PRESS RELEASES

Verastem Oncology Announces Presentation Of Updated Phase 1/2 FRAME Study Data At The 2nd Annual RAS-Targeted Drug Development Summit

  • By Business Wire
  • Sep 16, 2020 7:00 AM EDT
PRESS RELEASES

Verastem Oncology To Present At Upcoming Investor Conferences

  • By Business Wire
  • Sep 10, 2020 4:05 PM EDT
PRESS RELEASES

Verastem Oncology Signs Definitive Agreement To Sell COPIKTRA® (duvelisib) Rights To Secura Bio To Focus On Development Of VS-6766 And Defactinib In KRAS Mutant Solid Tumors

  • By Business Wire
  • Aug 10, 2020 8:30 AM EDT
PRESS RELEASES

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • By Business Wire
  • Jul 6, 2020 7:00 AM EDT
PRESS RELEASES

Verastem Oncology Announces Presentation Of Preclinical Data Supporting The Combination Of VS-6766 And Defactinib In Metastatic Uveal Melanoma

  • By Business Wire
  • Jun 22, 2020 4:05 PM EDT
PRESS RELEASES

Verastem Oncology To Present At The Jefferies Virtual Healthcare Conference

  • By Business Wire
  • May 28, 2020 7:00 AM EDT
PRESS RELEASES

Verastem Oncology Appoints John H. Johnson To Its Board Of Directors

  • By Business Wire
  • Apr 23, 2020 8:38 AM EDT
PRESS RELEASES

Verastem Oncology Announces 2020 Annual Meeting Of Stockholders To Be Held As Virtual Meeting

  • By Business Wire
  • Apr 21, 2020 5:18 PM EDT
PRESS RELEASES

Verastem Oncology Announces Investor Conference Call To Discuss Clinical Data From Investigator-initiated RAF/MEK And FAK Combination Study In KRAS Mutant Solid Tumors

  • By Business Wire
  • Apr 20, 2020 7:00 AM EDT
PRESS RELEASES

Verastem Oncology Announces Presentation Of Clinical Data From Investigator-initiated RAF/MEK And FAK Combination Study In KRAS Mutant Solid Tumors At The American Association For Cancer Research 2020 Virtual Annual Meeting I

  • By Business Wire
  • Apr 13, 2020 6:05 PM EDT
PRESS RELEASES

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • By Business Wire
  • Apr 7, 2020 4:05 PM EDT
PRESS RELEASES

Verastem Oncology Announces New Strategic Direction To Advance Its Clinical Development Programs

  • By Business Wire
  • Feb 28, 2020 6:05 AM EST
PRESS RELEASES

Verastem Oncology Announces $100 Million Private Placement Offering Of Common Stock To Premier Life Sciences Investors

  • By Business Wire
  • Feb 28, 2020 6:00 AM EST
PRESS RELEASES

Verastem Oncology Announces Dosing Of First Patient In CSPC's Chinese Study Evaluating COPIKTRA® (Duvelisib) In Patients With Relapsed Or Refractory Follicular Lymphoma

  • By Business Wire
  • Jan 29, 2020 7:06 AM EST
PRESS RELEASES

Verastem Oncology Announces Global Licensing Agreement With Chugai Pharmaceutical Co., Ltd. To Develop And Commercialize RAF/MEK Inhibitor CH5126766

  • By Business Wire
  • Jan 8, 2020 7:00 AM EST
Where's the Real Leadership?: Cramer's 'Mad Money' Recap (Monday 4/30/18)
JIM CRAMER

The Power of Personalization: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 24, 2018 11:04 PM EDT
This Is Ferrari's Key Support After Post-Earnings Breakout
JIM CRAMER

Ferrari, Paychex, First American: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Oct 24, 2018 11:04 PM EDT
Verastem Shares Are Exploding 50% -- Here's Why
HEALTH

Verastem Shares Jump On Cancer Drug Data - Biotech Movers

  • By Armie Margaret Lee
  • Sep 6, 2017 11:11 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.